Weight loss pill ‘could be deadly’
January 17th, 2010 - 3:03 pm ICT by ANIMelbourne, Jan 17 (ANI): A weight-loss pill popular in Australia has been found to be potentially fatal.
Therapeutic Goods Administration has ordered doctors to stop prescribing the drug to the overweight after a clinical trial showed its hazardous effects, reports the Daily Telegraph.
The decision has driven women desperate to obtain the drug sibutramine, marketed as Reductil, to the Internet to get around the ban.
The TGA has imposed restrictions after almost 200 reports of adverse reactions to the drug.
Reductil has been linked to strokes, high blood pressure, thyroid problems, anxiety and at least one death in Australia.
The circular warns that the fat-busting drug could harm the people it was aimed at - the overweight.
“Based on the preliminary results of the Sibutramine Cardiovascular Outcomes Trial (SCOUT), changes have been made to the Australian product information to highlight that sibutramine must not be prescribed to patients with a history of cardiovascular disease and/or hypertension,” it states.
It added: “In summary, the SCOUT study suggested potential for harm in patients who are overweight or obese and at high risk of a CV (cardiovascular) event.” (ANI)
- Weight loss pill linked to heart attacks, stroke risk - Jan 04, 2010
- China bans 15 products over heart disease concern - Nov 01, 2010
- 'Nothing natural about 'Natural Viagra' being sold online' - May 03, 2011
- Europe bans anti-obesity drug Reductil - Jan 26, 2010
- Quit-smoking drug 'instigates suicidal tendencies' - Aug 04, 2010
- Keller Rohrback to continue investigation of Abbot Laboratories' weight loss drug Merida - Oct 10, 2010
- Quit-smoking drug linked to suicides - Aug 05, 2010
- Three-pill combo for high BP launched - Nov 22, 2011
- Obesity drug withdrawn over heart attack, stroke risk - Jan 22, 2010
- Fat zappers 'may just be a fad after all' - Sep 12, 2010
- Fat-busting pill helps shed two pounds a week - Jan 12, 2011
- Weight-loss drug increases blood pressure: Review - Jul 10, 2009
- A heart pill that halves risk of death - Nov 15, 2010
- Keller Rohrback investigates Abbot Laboratories regarding weight loss drug - Oct 10, 2010
- Abbott Laboratories Allows Further Investigation On Meridia - Oct 10, 2010
Tags: adverse reactions, anxiety, cardiovascular event, cardiovascular outcomes, clinical trial, daily telegraph, hazardous effects, high blood pressure, high risk, history of cardiovascular disease, hypertension, overweight, preliminary results, reductil, scout, strokes, tga, therapeutic goods administration, thyroid, thyroid problems